Nobuhiro Nishii

Medicine & Life Sciences

1. 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol 12%
2. 4-hydroxy-2-nonenal 6%
3. alternan 5%
4. Atrial Fibrillation 10%
5. Atrial Heart Septal Defects 5%
6. Brain Natriuretic Peptide 7%
7. Brugada Syndrome 100%
8. Bundle-Branch Block 9%
9. Cardiac Arrhythmias 17%
10. Cardiac Resynchronization Therapy 21%
11. Cardiac Resynchronization Therapy Devices 7%
12. Catheter Ablation 7%
13. Coronary Artery Disease 5%
14. Databases 5%
15. Defibrillators 17%
16. Dilated Cardiomyopathy 6%
17. Electric Impedance 11%
18. Electrocardiography 24%
19. Equipment and Supplies 20%
20. Fontan Procedure 5%
21. Heart Failure 26%
22. Heart Ventricles 6%
23. Hemodynamics 5%
24. Hospitalization 8%
25. Hypertrophic Cardiomyopathy 8%
26. Implantable Defibrillators 40%
27. Japan 14%
28. Lead 23%
29. Long QT Syndrome 6%
30. Mutation 7%
31. Oxidative Stress 5%
32. pilsicainide 7%
33. Primary Prevention 10%
34. Pulmonary Arterial Hypertension 5%
35. Registries 13%
36. Sarcoidosis 10%
37. Shock 6%
38. Sodium Channel Blockers 9%
39. Stroke Volume 5%
40. Sudden Cardiac Death 7%
41. Syncope 13%
42. Tachycardia 13%
43. Therapeutics 5%
44. Torsades de Pointes 5%
45. Ventricular Fibrillation 53%
46. Ventricular Premature Complexes 7%
47. Ventricular Tachycardia 19%
48. voglibose 8%